Our People


Dimitrios J Angelis, JD

     Dimitrios has spent his career both on the “legal side” as a General Counsel, and on the “business side” as a CEO of a public company, thereby allowing him the breadth of experience to better understand the value of sound legal advice together with good business judgment.

     The majority of Dimitrios’ time has been in the life sciences advising on a broad spectrum of matters. This includes drafting a wide range of contracts, conducting negotiations, running cross-border transactions, mergers and acquisitions, advising on securities law, global patent strategy, litigation strategy, compliance, employment law, initial public offerings, private placements, and real estate matters.

     Dimitrios has advised clients at every stage of their development including the start-up stage, raising private and public capital, doing roadshows, the IPO, managing investor relations, preparing for a sale, and negotiating the sale of companies.                       

     Dimitrios currently sits on three public company boards and advises clients in ways that highlight the culmination of his broad legal experiences and his unique executive officer posts. Common sense, good judgment and the ability to negotiate exceptionally well underline the valuable advice Dimitrios gives.

Direct: +1 973-524-6480

Mobile: +1-914-772-9973

Email: da@pharmatechlaw.com


Andrew Berks, JD, PhD

     Andy is an experienced patent attorney who helps his clients obtain and enforce their patent rights. Understanding client needs and business objectives is a critical factor that sets him apart from other patent attorneys.

     Andy has significant experience counseling clients, developing patent strategies, and evaluating legal issues. His practice includes patent prosecution, patent litigation, drafting and negotiating licenses and research agreements, patent opinion work, biosimilars, and Hatch-Waxman practice (paragraph IV strategies and notice letters). Andy’s technical background is in chemistry, and he focuses on the life sciences and chemical arts, but he has successfully prosecuted and litigated matters in all patent subject areas.

     Andy is licensed in New York, New Jersey, the United States Patent and Trademark Office, the United States Federal Courts and the courts in New York and New Jersey. He holds a Ph.D. in Chemistry from the University of Colorado and a J.D. from Fordham Law School.

Direct: +1 646-797-2952
Mobile: +1 845-558-7245


Smitha Murthy, MBA

Smitha is an experienced Product Management Executive and Technologist with expertise in driving innovative customer experiences through Digital Transformation, Data Science and Analytics. She has a successful track record of managing multi-million-dollar product lines and P&L, commercializing digital products from concept to launch in Cybersecurity, Governance, Risk and Compliance, InsureTech, HRTech, and Enterprise Storage domains. More broadly, her breadth and depth of expertise in technology allows her to learn new domains quickly and to bring immediate value to all commercialization processes, technology investments, M&A and partnerships.

In addition, Smitha brings a wealth of experience in offshore hiring and setting up operations for startups to large multinational organizations.

Smitha currently acts as an advisor to various technology startups in ways that highlight the culmination of her deep technology and product experiences and her unique global positions.

She holds a bachelor's degree in Computer Engineering from Louisiana State University and an MBA from Carnegie Mellon University.

Direct: +1-973-524-6480

Mobile: +1-516-884-8274

Email: sm@pharmatechlaw.com


 “If we don’t transform the world, who will? If not now, when?”    -- Anonymous